Inhibrx Biosciences, Inc. · NASDAQ:INBX

Viking Global Investors LP reported a 9.30% stake in Inhibrx Biosciences, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Viking Global Investors LP reported a 9.30% stake in Inhibrx Biosciences, Inc., 1,383,621 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
9.30%
Shares
1,383,621
Intent
Passive
What changed
Stake changed
Filed together
11 holders

The filing in full

HolderStakeShares
VIKING GLOBAL INVESTORS LP9.30%1,383,621
Viking Global Opportunities Parent GP LLC9.30%1,383,621
Viking Global Opportunities GP LLC8.70%1,303,208
Viking Global Opportunities Portfolio GP LLC8.40%1,250,816
Viking Global Opportunities Illiquid Investments Sub-Master LP8.40%1,250,816
KAVRA 104 LLC0.40%52,392
Viking Global Opportunities Drawdown GP LLC0.50%80,413
Viking Global Opportunities Drawdown Portfolio GP LLC0.50%80,413
Viking Global Opportunities Drawdown (Aggregator) LP0.50%80,413
HALVORSEN OLE ANDREAS9.30%1,383,621
Shabet Rose Sharon9.30%1,383,621

Source

View original at SEC

Related